GDR.LSE genedrive plc

Healthcare Biotechnology London Exchange
0.0095 GBX
Close of Nov 3, 2026
0.7000 1.55
Market cap
GBX 15.3M
P/E
-
P/B
0.78x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Dec 2025.

Is GDR.LSE undervalued?

Graham number

The Graham number of genedrive plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

genedrive plc fundamental analysis

No fundamental analysis for genedrive plc yet.

genedrive plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About genedrive plc

genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides Genedrive system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a certified test for identification of …

Full company profile